MOH vs CVS vs ELV Stock Comparison

Molina Healthcare, Cvs Health and Elevance Health Prices as of Nov 13, 2026 Peers: Industry group
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$11.61B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
2 wins
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$113.19B
P/E
10.3x
Revenue (TTM)
$420.61B
Div. yield
–
Managed Care Healthcare
8 wins
ELV Elevance Health, Inc.
$429.67 +0.4% 1M +30.9% 1Y
Market cap
$95.95B
P/E
18.7x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
1 win

Head to Head

11 decided of 12

Cvs Health leads on 8 of the 12 questions below (Cvs Health 8, Molina Healthcare 2, Elevance Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMOHCVSELVLeader
Larger companyMarket capitalisation $11.61B $113.19B $95.95B CVS
Cheaper on earningsLower P/E, profitable companies only -241.9x 10.3x 18.7x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 41.0x 10.2x 14.3x CVS
Faster revenue growthRevenue growth, trailing twelve months -0.9% +6.7% +3.6% CVS
More profitableNet margin, trailing twelve months -0.1% 2.6% 2.5% CVS
Better return on capitalReturn on invested capital 2.2% 9.7% 8.3% CVS
Less leveragedLower net debt / EBITDA -14.4x 2.3x -0.5x MOH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +51.4% +12.7% +30.9% MOH
Better 5-year returnAnnualised price return, 5 years -7.7%/yr -1.0%/yr -0.3%/yr ELV
Less volatileAnnualised volatility, 1 year 52.5% 35.1% 35.6% CVS
Higher overall scoreMean of the five percentile scores vs peers 36/100 72/100 68/100 CVS

Percentile Scorecard

MOHCVSELV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMOHCVSELV
Valuation 42 #16 of 27 100 #1 of 27 81 #6 of 27
Growth 4 #25 of 26 80 #6 of 26 36 #17 of 26
Profitability 32 #18 of 26 84 #5 of 26 72 #8 of 26
Financial Health 64 #10 of 26 24 #20 of 26 68 #9 of 26
Shareholder Returns – 71 #6 of 18 82 #4 of 18
Overall 36 72 68
  • MOH ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors
  • ELV ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMOHCVSELVSPY
1 month +0.3%-1.2%+0.4% -2.0%
3 months -1.3%-8.1%+7.3% -2.8%
6 months +13.3%-6.8%+9.4% +2.0%
Year to date +20.8%+12.6%+22.6% +10.6%
1 year +51.4%+12.7%+30.9% +12.2%
3 years -42.2%+30.4%-6.9% +68.1%
3 years, per year -16.7%+9.3%-2.4% +18.9%
5 years -33.1%-5.0%-1.7% +61.4%
5 years, per year -7.7%-1.0%-0.3% +10.1%
10 years +341.0%+19.0%+221.4% +248.5%
10 years, per year +16.0%+1.8%+12.4% +13.3%

Risk

MeasureMOHCVSELVSPY
Volatility, 1Y 52.5%35.1%35.6% 13.6%
Downside volatility, 1Y 57.9%38.8%38.1% 13.9%
Beta vs S&P 500, 1Y -0.01-0.050.29 1.00
Return / volatility, 1Y 0.980.360.87 0.90
Max drawdown, 5Y -70.8%-60.5%-51.2% -25.4%
From 52-week high -13.7%-19.2%-3.5% -3.2%
52-week high $242.88$110.55$445.45 $779.14
52-week low $122.65$70.08$280.74 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMOHCVSELV
P/E now vs peer median -223.6xmedian 25.2x 10.4xmedian 25.2x 18.1xmedian 25.2x
P/S now vs peer median 0.2xmedian 0.4x 0.3xmedian 0.4x 0.5xmedian 0.4x
EV/EBITDA now vs peer median 18.3xmedian 14.5x 8.2xmedian 14.5x 9.6xmedian 14.5x
P/FCF now vs peer median 45.8xmedian 16.5x 7.3xmedian 16.5x 14.3xmedian 16.5x
P/B now vs peer median 2.6xmedian 2.7x 1.4xmedian 2.7x 2.1xmedian 2.7x
PEG now vs peer median 8.22median 1.72 1.22median 1.72 -7.75median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMOHCVSELV
Revenue $44.13B $420.61B $201.83B
Gross profit $5.56B $186.06B $53.35B
Operating income $172.00M $15.06B $7.70B
Net income -$48.00M $11.09B $5.13B
Free cash flow $238.00M $15.57B $6.51B
EPS (diluted) $-0.93 $8.55 $23.62
Cash & equivalents $4.48B $11.74B $10.35B
Total debt $3.77B $60.68B $30.76B
Shares (diluted) 51.50M 1.29B 217.60M
Enterprise value -$23.39B $61.95B -$46.64B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMOHCVSELV
P/E -223.6x 10.4x 18.1x
P/FCF 45.8x 7.3x 14.3x
P/Operating cash flow 32.9x 6.1x 12.2x
P/S 0.2x 0.3x 0.5x
P/B 2.6x 1.4x 2.1x
P/Tangible book 2.6x 2.0x 2.7x
EV/EBITDA 18.3x 8.2x 9.6x
EV/EBIT 35.4x 10.6x 11.4x
EV/Revenue 0.1x 0.4x 0.4x
EV/FCF 25.6x 10.3x 13.5x
EV/Operating cash flow 18.4x 8.6x 11.6x
PEG (3Y EPS CAGR) 8.22 1.22 -7.75

Growth

14 metrics
MetricMOHCVSELV
Revenue growth (1Y) -0.9% 6.7% 3.6%
Revenue CAGR (3Y) 9.9% 6.5% 6.2%
Gross profit growth (1Y) -10.2% 5.3% 4.3%
Gross profit CAGR (3Y) 3.3% 10.9% 5.5%
Operating income growth (1Y) -87.0% 206.4% -9.2%
Operating income CAGR (3Y) -49.8% 2.4% -4.2%
Net income growth (1Y) -105.4% 2,369% -7.4%
Net income CAGR (3Y) -27.1% 8.6% -5.2%
EPS growth (1Y) -105.5% 2,213% -4.5%
EPS CAGR (3Y) -27.2% 8.5% -2.3%
Operating cash flow growth (1Y) 171.8% 105.4% 54.6%
Operating cash flow CAGR (3Y) -46.3% 9.9% -7.2%
Free cash flow growth (1Y) 141.5% 147.4% 72.9%
Free cash flow CAGR (3Y) -51.1% 11.3% -7.6%

Profitability

14 metrics
MetricMOHCVSELV
Gross margin 12.6% 44.2% 26.4%
EBITDA margin 0.8% 4.7% 4.6%
Operating margin 0.4% 3.6% 3.8%
Pretax margin -0.1% 2.9% 3.1%
Net margin -0.1% 2.6% 2.5%
FCF margin 0.5% 3.7% 3.2%
Operating cash flow margin 0.8% 4.4% 3.8%
Return on equity -1.2% 13.8% 11.4%
Return on assets -0.3% 4.3% 4.0%
Return on invested capital 2.2% 9.7% 8.3%
Return on capital employed 2.0% 9.2% 9.6%
Asset turnover 2.8x 1.6x 1.6x
Cash conversion (OCF / net income) -6.9x 1.7x 1.5x
Stock comp / revenue 0.2% 0.2% 0.1%

Financial Health

11 metrics
MetricMOHCVSELV
Debt / assets 24.1% 23.5% 24.1%
Debt / equity 0.9x 0.8x 0.7x
Net debt / EBITDA -14.4x 2.3x -0.5x
Debt / FCF 15.8x 3.9x 4.7x
Liabilities / assets 73.5% 68.7% 65.0%
Equity / assets 26.5% 31.3% 35.0%
Interest coverage 0.8x 4.9x 5.3x
Current ratio 1.7x 0.9x 1.5x
Quick ratio 1.6x 0.8x 1.2x
Cash ratio 1.2x 0.2x 0.8x
Altman Z-score 4.15 2.51 3.06

Shareholder Returns

7 metrics
MetricMOHCVSELV
Dividend yield – 3.0% 1.6%
Net buyback yield – -0.4% 2.2%
Shareholder yield – 2.6% 3.8%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMOHCVSELV
Forward P/E 41.0xFY2026 10.2xFY2026 14.3xFY2026
EPS, next fiscal year $5.11FY2026 $8.80FY2026 $30.12FY2026
EPS growth, next FY -53.7%FY2026 +30.4%FY2026 -0.6%FY2026
EPS growth, the year after +93.0% +1.1% +4.2%
Revenue, next fiscal year $41.59BFY2026 $431.16BFY2026 $211.92BFY2026
Revenue growth, next FY -8.5%FY2026 +7.2%FY2026 +7.3%FY2026
Revenue growth, the year after +20.4% -5.3% +0.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMOHCVSELV
Held by institutions 100.0% 89.1% 91.8%
Institutions holding 600 2,074 1,615
Change in shares held, QoQ +1.2% +3.5% +1.7%
Institutions buying 364 1,103 862
Institutions selling 170 733 542
Buyers to sellers 2.14 1.50 1.59

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MOHCVSELV
MOH 1.00 0.21 0.46
CVS 0.21 1.00 0.42
ELV 0.46 0.42 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MOH, CVS and ELV?

Cvs Health (CVS) is the largest by market capitalisation: Molina Healthcare (MOH) $11.61B, Cvs Health (CVS) $113.19B, Elevance Health (ELV) $95.95B.

Which stock is cheaper, MOH, CVS and ELV?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Molina Healthcare (MOH) -241.9x, Cvs Health (CVS) 10.3x, Elevance Health (ELV) 18.7x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Molina Healthcare (MOH) 41.0x, Cvs Health (CVS) 10.2x, Elevance Health (ELV) 14.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cvs Health (CVS) grew revenue fastest over the trailing twelve months: Molina Healthcare (MOH) -0.9%, Cvs Health (CVS) +6.7%, Elevance Health (ELV) +3.6%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Molina Healthcare (MOH) -0.1%, Cvs Health (CVS) 2.6%, Elevance Health (ELV) 2.5%). On return on invested capital, Cvs Health (CVS) leads (Molina Healthcare (MOH) 2.2%, Cvs Health (CVS) 9.7%, Elevance Health (ELV) 8.3%).

Which stock has performed better?

Over the past year Molina Healthcare (MOH) returned the most: Molina Healthcare (MOH) +51.4%, Cvs Health (CVS) +12.7%, Elevance Health (ELV) +30.9%. Over five years, Elevance Health (ELV) compounded fastest (Molina Healthcare (MOH) -7.7%/yr, Cvs Health (CVS) -1.0%/yr, Elevance Health (ELV) -0.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Molina Healthcare (MOH) 52.5%, Cvs Health (CVS) 35.1%, Elevance Health (ELV) 35.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MOH, CVS and ELV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.